Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Antibody-Mediated Rejection of Solid-Organ Allografts This review focuses on current
standards for management of antibody-mediated rejection in solid-organ transplant …

This meeting was organized by The Transplantation Society with the assistance of an
unconditional education grant from CSL Behring. CSL Behring had no involvement in the …

Chronic inflammatory lesions of the placenta are characterized by the infiltration of the organ
by lymphocytes, plasma cells, and/or macrophages and may result from infections (viral …

Background The introduction of solid-phase immunoassay (SPI) technology for the detection
and characterization of human leukocyte antigen (HLA) antibodies in transplantation while …

The presence of preexisting (memory) or de novo donor‐specific HLA antibodies (DSAs) is a
known barrier to successful long‐term organ transplantation. Yet, despite the fact that …

Background A report from a high-volume single center indicated a survival benefit of
receiving a kidney transplant from an HLA-incompatible live donor as compared with …

Background More than 20,000 candidates for kidney transplantation in the United States are
sensitized to HLA and may have a prolonged wait for a transplant, with a reduced …

Advances in multimodal immunotherapy have significantly reduced acute rejection rates and
substantially improved 1-year graft survival following renal transplantation. However, long …

Sensitized renal transplant recipients with high levels of donor-specific alloantibody (DSA)
commonly develop antibody-mediated rejection (AMR), which may cause acute graft loss or …